| Financial Year |
March 31 2023 |
| Monetary Funds |
229,589,194.02 |
| Held-for-trading Financial Assets |
6,405,555.53 |
| Notes Receivable |
202,610,694.61 |
| Accounts Receivable |
625,178,800.05 |
| Advances to Suppliers |
18,455,013.48 |
| Other Receivables |
29,029,325.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,156,284.00 |
| Inventories |
606,424,482.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,070,686.30 |
| Other Current Assets |
16,405,546.97 |
| Total Current Assets |
1,812,282,537.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
11,298,981.50 |
| Long-term Equity Investment |
37,765,022.60 |
| Investment Properties |
-- |
| Fixed Assetes |
742,648,411.38 |
| Under-construction Projects |
12,771,906.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
49,441,999.58 |
| R&D expenses |
-- |
| Goodwill |
4,200,057.35 |
| Long-Term Deferred and Prepaid Expenses |
18,799,039.42 |
| Deferred Income Tax Assets |
37,274,737.46 |
| Other Non-Current Assets |
12,245,702.39 |
| Sub-Total of Non-Current Assets |
1,014,473,479.74 |
| Total Assets |
2,826,756,017.18 |
| Short-Term Loans |
178,546,705.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
199,113,401.46 |
| Accounts Payable |
585,747,443.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,134,876.50 |
| Taxes Payable |
11,755,377.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,186,586.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
121,617,116.62 |
| Other Current Liabilities |
302,562,379.66 |
| Sub-Total of Current Liabilities |
1,469,346,345.38 |
| Long-term Loans |
80,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
123,237,297.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,644,927.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
240,313,594.36 |
| Total Liabilities |
1,709,659,939.74 |
| Paid-In Capital(Or Share Stock) |
211,220,000.00 |
| Capital Surplus |
473,927,445.84 |
| Surplus Reserve |
52,493,912.68 |
| LESS:Treasury Stock |
9,064,600.00 |
| Undistributed Profits |
367,425,512.97 |
| Minority Stockholder's Interest |
20,693,405.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,096,402,672.23 |
| Owner's Equity（Stockholder's Equity） |
1,117,096,077.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,826,756,017.18 |
